Start Forschung Abteilungen / AGs / Institute Molekulares Neuroimaging Publikationen

Publikationen: Molekulares Neuroimaging

Gründer G. [Digital phenotyping. Contra]. Nervenarzt. 2020 91(9):860-862. Epub 2020 Mar 31.
Kuzin M, Bochon B, Vagiaris E, Dammann G, Gründer G, Paulzen M, Schoretsanitis G. Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia. J Clin Psychopharmacol. 2020 40(3):306-308.
Kuzin M, Schoretsanitis G, Haen E, Dammann G, Hiemke C, Gründer G, Paulzen M. The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism. Pharmacopsychiatry. 2020 53(2):65-70. Epub 2019 Oct 15.
Kuzin M, Schoretsanitis G, Haen E, Ridders F, Hiemke C, Gründer G, Paulzen M. Pharmacokinetic interactions between clozapine and sertraline in smokers and non-smokers. Basic Clin Pharmacol Toxicol. 2020 127(4):303-308. Epub 2020 Apr 19.
Meinhardt M, Güngör C, Skorodumov I, Mertens L, Spanagel R. Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. Neuropsychopharmacology. 2020 45(8):1316-1322. Epub 2020 May 5.
Mertens L, Gruender G. Klassische Psychedelika als Therapeutika in der Psychiatrie. Psychopharmakotherapie. 2020 27:171-180.
Mertens L, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. J Psychopharmacol. 2020 34(2):167-180.
Paulzen M, Schoretsanitis G, Gründer G, Franz C, Stingl JC, Augustin M. Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes. J Affect Disord. 2020 266:578-584. Epub 2020 Feb 3.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J. A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. Eur Arch Psychiatry Clin Neurosci. 2020 270(1):83-94. Epub 2019 Sep 5.
Schoretsanitis G, Kane JM, Correll CU, Marder SR, Citrome L, Newcomer JW, Robinson DG, Goff DC, Kelly DL, Freudenreich O, Piacentino D, Paulzen M, Conca A, Zernig G, Haen E, Baumann P, Hiemke C, Gründer G, American Society of Clinical Psychopharmacology , Pharmakopsychiatrie TTDMTFOTAFNU. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakolog. J Clin Psychiatry. 2020 81(3)
Schredl M, Bailer CB, Weigel MS, Welt MS. Dreaming about Dogs: An Online Survey. Animals (Basel). 2020 10(10)
Wolff M, Evens R, Mertens L, Koslowski M, Betzler F, Gründer G, Jungaberle H. Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance. Front Psychiatry. 2020 11:5.
Zeifman RJ, Wagner AC, Watts R, Kettner H, Mertens L, Carhart-Harris RL. Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation. Front Psychiatry. 2020 11:782.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de